TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 48 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q2 2016. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $559,000 | -79.1% | 231,974 | -33.5% | 0.08% | -70.7% |
| Q4 2015 | $2,674,000 | +51.0% | 348,641 | +4.2% | 0.26% | +67.1% |
| Q3 2015 | $1,771,000 | -37.4% | 334,689 | +6.2% | 0.16% | -22.9% |
| Q2 2015 | $2,828,000 | +60.3% | 315,259 | +12.9% | 0.20% | +42.6% |
| Q1 2015 | $1,764,000 | +17.2% | 279,141 | +8.3% | 0.14% | +36.9% |
| Q4 2014 | $1,505,000 | -12.1% | 257,761 | +3.1% | 0.10% | -12.7% |
| Q3 2014 | $1,713,000 | -46.9% | 250,000 | +11.1% | 0.12% | -30.6% |
| Q2 2014 | $3,229,000 | +29.5% | 225,000 | -6.1% | 0.17% | +77.1% |
| Q1 2014 | $2,493,000 | – | 239,500 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|